Patient Information

LYRICA (Pregabalin)

 

General Guidelines:

Adequate trial at a given dose might take 4-6 weeks

Minimize side effects:

  • Start at lower dose --- then increase dose slowly
  • Adverse effects experienced by some patients include sedation and dizziness, which tend to improve and resolve during the initial period of use.
  • Consider combining treatment with Lyrica with another class of drug used to treat neuropathic pain (e.g. Cymbalta)

 

Dosage Schedule

Maximum Total Daily

Dose

Week 1-   50 mg  TID

150 mg

Week 2 -   100 mg  TID

300 mg

 

Side effects of LYRICA:

  • Dizziness
  • Sleepiness
  • Dry mouth
  • Swelling of hands and feet
  • Blurry vision
  • Weight gain
  • Trouble concentrating

 

For a complete list of side effects, see the Patient Product Information for LYRICA.

 

 

 

 

 

- Back to Patient Information - Back to Top 

 


Medication


The topics presented on this site are for informational purposes only. Any decision you make regarding your health care options should be made after consulting a qualified physician provider.

1.  CLONIDINE
2.  LYRICA
3.  METHADONE
4.  CYMBALTA
5.  CELEBREX


The RSD / CRPS Treatment Center and Research Institute is a licensed Ambulatory Surgical Center that is approved by the Florida Board of Medicine for Level II surgery.

The facility is regulated pursuant to the rules of the Board of Medicine as set forth in Rule Chapter 64B8, F.A.C.



 

Recent Articles

How to Determine the Effectiveness of Treatments for RSD / CRPS
Dr. Anthony F. Kirkpatrick, Chairman, Scientific Advisory Committee.



Ketamine Coma Procedure
Efficacy of Ketamine in Anesthetic Dosage for the Treatment of Refractory Complex Regional Pain Syndrome: An Open-Label Phase II Study.



Medical Synopsis Prepared for Ketamine Coma Procedure
Research subjects discuss the risks and benefits of the ketamine coma procedure. This information is presented for patients who may be contemplating the procedure.


The International Research Foundation for RSD / CRPS is a 501(c)(3) (not-for-profit) organization in the United States of America.